HMVYX | VMVAX | HMVYX / VMVAX | |
Total Expense Ratio | 0.87 | 0.07 | 1,243% |
Annual Report Gross Expense Ratio | 0.87 | 0.07 | 1,243% |
Fund Existence | 24 years | 14 years | - |
Gain YTD | 3.244 | 7.952 | 41% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 3000 | 8,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.15B | 32.5B | 4% |
Annual Yield % from dividends | 0.79 | 2.17 | 36% |
Returns for 1 year | -7.76 | 4.87 | -159% |
Returns for 3 years | 12.27 | 42.44 | 29% |
Returns for 5 years | 34.30 | 64.89 | 53% |
Returns for 10 years | 20.32 | 102.58 | 20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFAK | 132.05 | N/A | N/A |
Stone Ridge 2052 Longevity Income ETF | |||
OVB | 20.58 | -0.03 | -0.15% |
Overlay Shares Core Bond ETF | |||
FIDI | 24.52 | -0.12 | -0.48% |
Fidelity International High Div ETF | |||
EMXC | 68.93 | -0.53 | -0.76% |
iShares MSCI Emerging Mkts ex China ETF | |||
EQAL | 52.25 | -0.44 | -0.84% |
Invesco Russell 1000 Equal Weight ETF |